Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921885> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q61921885 description "assaig clínic" @default.
- Q61921885 description "clinical trial" @default.
- Q61921885 description "clinical trial" @default.
- Q61921885 description "clinical trial" @default.
- Q61921885 description "clinical trial" @default.
- Q61921885 description "ensaio clínico" @default.
- Q61921885 description "ensayo clínico" @default.
- Q61921885 description "ensayu clínicu" @default.
- Q61921885 description "essai clinique" @default.
- Q61921885 description "klinisch onderzoek" @default.
- Q61921885 description "клінічне випробування" @default.
- Q61921885 description "կլինիկական փորձարկում" @default.
- Q61921885 name "A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness" @default.
- Q61921885 type Item @default.
- Q61921885 label "A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness" @default.
- Q61921885 prefLabel "A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness" @default.
- Q61921885 P1132 Q61921885-1F080560-8114-40C4-B03E-F8B887B0B896 @default.
- Q61921885 P1476 Q61921885-3F4F9C65-1F7B-4B6C-BEDF-5CCD89F2BDA9 @default.
- Q61921885 P17 Q61921885-06557C74-5380-49CE-9DDF-C1477EAF4595 @default.
- Q61921885 P17 Q61921885-7C21FB41-7C2E-42E8-8694-9C186BE9B6D3 @default.
- Q61921885 P17 Q61921885-A769796E-D162-42BE-AB77-8D1A6EB82819 @default.
- Q61921885 P17 Q61921885-DE35C2F6-F8AD-4A0B-8A1A-B88F1626A9CE @default.
- Q61921885 P17 Q61921885-F5E10D91-BAD6-4092-8157-DDB7316BA06E @default.
- Q61921885 P3098 Q61921885-927C1CBC-8167-419C-8240-6D704490AB2D @default.
- Q61921885 P31 Q61921885-78BB38CB-88E6-4DBE-8AAB-D46FA1E81A19 @default.
- Q61921885 P4135 Q61921885-AFBAB3E8-3957-4F88-887B-E0B4E4DB8D79 @default.
- Q61921885 P580 Q61921885-A47F8832-AB60-4BE1-873A-17D8009725C9 @default.
- Q61921885 P582 Q61921885-C7E5AD33-2936-4F5C-A36F-362D008905D0 @default.
- Q61921885 P6099 Q61921885-1CCC2FA7-DEF2-40A7-A252-DE8A5864E281 @default.
- Q61921885 P8363 Q61921885-A43057E6-E0FE-4CAD-ADC2-1AE1770E77CA @default.
- Q61921885 P1132 "+118" @default.
- Q61921885 P1476 "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized With RSV Illness" @default.
- Q61921885 P17 Q298 @default.
- Q61921885 P17 Q30 @default.
- Q61921885 P17 Q408 @default.
- Q61921885 P17 Q664 @default.
- Q61921885 P17 Q804 @default.
- Q61921885 P3098 "NCT00421304" @default.
- Q61921885 P31 Q30612 @default.
- Q61921885 P4135 "+12" @default.
- Q61921885 P580 "2007-01-01T00:00:00Z" @default.
- Q61921885 P582 "2010-01-01T00:00:00Z" @default.
- Q61921885 P6099 Q42824440 @default.
- Q61921885 P8363 Q78089383 @default.